Literature DB >> 28539354

Cerebral oxygenation and regional cerebral perfusion responses with resistance breathing during central hypovolemia.

Victoria L Kay1, Justin D Sprick1, Caroline A Rickards2.   

Abstract

Resistance breathing improves tolerance to central hypovolemia induced by lower body negative pressure (LBNP), but this is not related to protection of anterior cerebral blood flow [indexed by mean middle cerebral artery velocity (MCAv)]. We hypothesized that inspiratory resistance breathing improves tolerance to central hypovolemia by maintaining cerebral oxygenation (ScO2), and protecting cerebral blood flow in the posterior cerebral circulation [indexed by posterior cerebral artery velocity (PCAv)]. Eight subjects (4 male/4 female) completed two experimental sessions of a presyncopal-limited LBNP protocol (3 mmHg/min onset rate) with and without (Control) resistance breathing via an impedance threshold device (ITD). ScO2 (via near-infrared spectroscopy), MCAv and PCAv (both via transcranial Doppler ultrasound), and arterial pressure (via finger photoplethysmography) were measured continuously. Hemodynamic responses were analyzed between the Control and ITD condition at baseline (T1) and the time representing 10 s before presyncope in the Control condition (T2). While breathing on the ITD increased LBNP tolerance from 1,506 ± 75 s to 1,704 ± 88 s (P = 0.003), both mean MCAv and mean PCAv were similar between conditions at T2 (P ≥ 0.46), and decreased by the same magnitude with and without ITD breathing (P ≥ 0.53). ScO2 also decreased by ~9% with or without ITD breathing at T2 (P = 0.97), and there were also no differences in deoxygenated (dHb) or oxygenated hemoglobin (HbO2) between conditions at T2 (P ≥ 0.43). There was no evidence that protection of regional cerebral blood velocity (i.e., anterior or posterior cerebral circulation) nor cerebral oxygen extraction played a key role in the determination of tolerance to central hypovolemia with resistance breathing.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  hemodynamic oscillations; hemorrhage; inspiratory threshold device; lower body negative pressure; middle cerebral artery; posterior cerebral artery

Mesh:

Substances:

Year:  2017        PMID: 28539354     DOI: 10.1152/ajpregu.00385.2016

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  5 in total

1.  Tolerance to a haemorrhagic challenge during heat stress is improved with inspiratory resistance breathing.

Authors:  Mu Huang; R Matthew Brothers; Matthew S Ganio; Rebekah A I Lucas; Matthew N Cramer; Gilbert Moralez; Victor A Convertino; Craig G Crandall
Journal:  Exp Physiol       Date:  2018-07-23       Impact factor: 2.969

2.  Hemorrhage simulated by lower body negative pressure provokes an oxidative stress response in healthy young adults.

Authors:  Flora S Park; Victoria L Kay; Justin D Sprick; Alexander J Rosenberg; Garen K Anderson; Robert T Mallet; Caroline A Rickards
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-06

3.  The impact of acute central hypovolemia on cerebral hemodynamics: does sex matter?

Authors:  Alexander J Rosenberg; Victoria L Kay; Garen K Anderson; My-Loan Luu; Haley J Barnes; Justin D Sprick; Hannah B Alvarado; Caroline A Rickards
Journal:  J Appl Physiol (1985)       Date:  2021-04-29

4.  A comparison of protocols for simulating hemorrhage in humans: step versus ramp lower body negative pressure.

Authors:  Alexander J Rosenberg; Victoria L Kay; Garen K Anderson; Justin D Sprick; Caroline A Rickards
Journal:  J Appl Physiol (1985)       Date:  2020-11-19

5.  CBF oscillations induced by trigeminal nerve stimulation protect the pericontusional penumbra in traumatic brain injury complicated by hemorrhagic shock.

Authors:  Chunyan Li; Kevin A Shah; Keren Powell; Yi-Chen Wu; Wayne Chaung; Anup N Sonti; Timothy G White; Mohini Doobay; Weng-Lang Yang; Ping Wang; Lance B Becker; Raj K Narayan
Journal:  Sci Rep       Date:  2021-10-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.